Trials / Completed
CompletedNCT05098522
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Allergen Challenge Trial of 6 Repeat Doses of IRL201104 in Adult Participants With Seasonal Allergic Rhinitis.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 63 (actual)
- Sponsor
- Revolo Biotherapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this allergen challenge study is to assess the efficacy of IRL201104 compared with placebo in adult participants with seasonal allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IRL201104 | lyophilised powder for reconstitution for IV dosing |
| DRUG | Placebo | Matching placebo for IRL201104 |
Timeline
- Start date
- 2021-11-04
- Primary completion
- 2023-03-27
- Completion
- 2023-03-27
- First posted
- 2021-10-28
- Last updated
- 2023-05-03
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05098522. Inclusion in this directory is not an endorsement.